CardioGenics Holdings Inc (CGNH)
USD 0.0
(99.0%)
USD 0.0
(99.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2015 | -772.14 Thousand USD | 20.68% |
| 2014 | -973.5 Thousand USD | 61.47% |
| 2013 | -2.52 Million USD | -92.34% |
| 2012 | -1.31 Million USD | 65.33% |
| 2011 | -3.78 Million USD | -91.18% |
| 2010 | -1.98 Million USD | 87.7% |
| 2009 | -16.11 Million USD | -808.4% |
| 2008 | -1.77 Million USD | -3.11% |
| 2007 | -1.72 Million USD | 26.69% |
| 2006 | -2.34 Million USD | -37.95% |
| 2005 | -1.7 Million USD | 14.25% |
| 2004 | -1.98 Million USD | 21.87% |
| 2003 | -2.53 Million USD | 36.77% |
| 2002 | -4.01 Million USD | 72.95% |
| 2001 | -14.84 Million USD | 0.46% |
| 2000 | -14.91 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2016 Q1 | -201.09 Thousand USD | 35.49% |
| 2015 Q4 | -311.73 Thousand USD | -212.03% |
| 2015 FY | -772.14 Thousand USD | 20.68% |
| 2015 Q1 | -205.69 Thousand USD | 33.32% |
| 2015 Q2 | -154.8 Thousand USD | 24.74% |
| 2015 Q3 | -99.9 Thousand USD | 35.47% |
| 2014 FY | -973.5 Thousand USD | 61.47% |
| 2014 Q3 | -197.45 Thousand USD | 3.86% |
| 2014 Q4 | -308.48 Thousand USD | -56.23% |
| 2014 Q1 | -262.17 Thousand USD | 86.04% |
| 2014 Q2 | -205.39 Thousand USD | 21.66% |
| 2013 Q4 | -1.87 Million USD | -704.13% |
| 2013 FY | -2.52 Million USD | -92.34% |
| 2013 Q3 | -233.62 Thousand USD | -20.99% |
| 2013 Q2 | -193.09 Thousand USD | 12.8% |
| 2013 Q1 | -221.43 Thousand USD | 38.25% |
| 2012 Q1 | -334.92 Thousand USD | 36.76% |
| 2012 Q4 | -358.62 Thousand USD | -53.04% |
| 2012 FY | -1.31 Million USD | 65.33% |
| 2012 Q3 | -234.34 Thousand USD | 39.26% |
| 2012 Q2 | -385.81 Thousand USD | -15.19% |
| 2011 FY | -3.78 Million USD | -91.18% |
| 2011 Q1 | -461.43 Thousand USD | 14.13% |
| 2011 Q2 | -624.44 Thousand USD | -35.33% |
| 2011 Q4 | -529.58 Thousand USD | 75.63% |
| 2011 Q3 | -2.17 Million USD | -248.06% |
| 2010 Q3 | -665.78 Thousand USD | -92.25% |
| 2010 FY | -1.98 Million USD | 87.7% |
| 2010 Q2 | -346.31 Thousand USD | 19.9% |
| 2010 Q1 | -432.35 Thousand USD | 96.75% |
| 2010 Q4 | -537.38 Thousand USD | 19.29% |
| 2009 Q1 | -423.8 Thousand USD | -79.24% |
| 2009 FY | -16.11 Million USD | -808.4% |
| 2009 Q4 | -13.3 Million USD | -397.71% |
| 2009 Q2 | -119.13 Thousand USD | 71.89% |
| 2009 Q3 | -2.67 Million USD | -2144.03% |
| 2008 Q3 | -261.85 Thousand USD | 53.97% |
| 2008 Q1 | -531.32 Thousand USD | -28.83% |
| 2008 FY | -1.77 Million USD | -3.11% |
| 2008 Q4 | -236.44 Thousand USD | 9.7% |
| 2008 Q2 | -568.87 Thousand USD | -7.07% |
| 2007 FY | -1.72 Million USD | 26.69% |
| 2007 Q4 | -412.41 Thousand USD | 42.78% |
| 2007 Q3 | -720.71 Thousand USD | -63.12% |
| 2007 Q2 | -441.84 Thousand USD | -41.14% |
| 2007 Q1 | -313.04 Thousand USD | -27.63% |
| 2006 Q4 | -245.27 Thousand USD | 46.28% |
| 2006 Q3 | -456.56 Thousand USD | 35.22% |
| 2006 Q2 | -704.75 Thousand USD | -6.12% |
| 2006 Q1 | -664.1 Thousand USD | -27.25% |
| 2006 FY | -2.34 Million USD | -37.95% |
| 2005 Q1 | -612.22 Thousand USD | -181.11% |
| 2005 FY | -1.7 Million USD | 14.25% |
| 2005 Q4 | -521.88 Thousand USD | -49.29% |
| 2005 Q3 | -349.57 Thousand USD | 33.03% |
| 2005 Q2 | -522.01 Thousand USD | 14.74% |
| 2004 Q2 | -713.58 Thousand USD | -170.39% |
| 2004 FY | -1.98 Million USD | 21.87% |
| 2004 Q4 | -217.79 Thousand USD | 56.48% |
| 2004 Q1 | -263.9 Thousand USD | 47.45% |
| 2004 Q3 | -500.44 Thousand USD | 29.87% |
| 2003 Q1 | -658.63 Thousand USD | -22.46% |
| 2003 Q4 | -502.25 Thousand USD | -19.58% |
| 2003 FY | -2.53 Million USD | 36.77% |
| 2003 Q3 | -420 Thousand USD | 54.52% |
| 2003 Q2 | -923.44 Thousand USD | -40.21% |
| 2002 Q3 | -792.41 Thousand USD | 20.66% |
| 2002 Q2 | -998.73 Thousand USD | 32.55% |
| 2002 Q1 | -1.48 Million USD | -98.66% |
| 2002 FY | -4.01 Million USD | 72.95% |
| 2002 Q4 | -537.82 Thousand USD | 32.13% |
| 2001 FY | -14.84 Million USD | 0.46% |
| 2001 Q3 | -756.64 Thousand USD | 47.47% |
| 2001 Q2 | -1.44 Million USD | 79.34% |
| 2001 Q1 | -6.97 Million USD | -22.29% |
| 2001 Q4 | -745.35 Thousand USD | 1.49% |
| 2000 Q1 | -3.11 Million USD | 0.0% |
| 2000 FY | -14.91 Million USD | 0.0% |
| 2000 Q4 | -5.7 Million USD | -10.49% |
| 2000 Q2 | -4.49 Million USD | -44.41% |
| 2000 Q3 | -5.15 Million USD | -14.8% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.24 Million USD | 37.831% |
| Arrayit Corporation | -3.62 Million USD | 78.685% |
| Atlantic International Corp. | -5.73 Million USD | 86.53% |
| Biocept, Inc. | -31.98 Million USD | 97.586% |
| Bioqual, Inc. | -19.63 Thousand USD | -3831.877% |
| DermTech, Inc. | -103.73 Million USD | 99.256% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.48 Billion USD | 100.031% |
| HTG Molecular Diagnostics, Inc. | -20.82 Million USD | 96.293% |
| iMD Companies, Inc. | -175.44 Thousand USD | -340.102% |
| IDenta Corp. | -1499.00 USD | -51410.474% |
| Interpace Biosciences, Inc. | 2.8 Million USD | 127.537% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | 2095.715% |
| InVitro International | -25.33 Thousand USD | -2947.247% |
| Lumos Diagnostics Holdings Limited | -7.12 Million USD | 89.158% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -1228.714% |
| Medical Imaging Corp. | -819.48 Thousand USD | 5.777% |
| NovelStem International Corp. | -3.52 Million USD | 78.1% |
| Optigenex Inc. | 1.39 Million USD | 155.516% |
| PharmChem, Inc. | 973.14 Thousand USD | 179.345% |
| Proteome Sciences plc | -1.62 Million USD | 52.366% |
| Response Genetics, Inc | -21.37 Million USD | 96.388% |
| Rennova Health, Inc. | -1.4 Million USD | 45.22% |
| RushNet, Inc. | -684.7 Thousand USD | -12.77% |
| ScreenPro Security Inc. | -2.59 Million USD | 70.215% |
| Stella Diagnostics Inc. | -11.42 Million USD | 93.243% |
| StageZero Life Sciences Ltd. | -7.74 Million USD | 90.033% |
| Todos Medical Ltd. | -9.74 Million USD | 92.079% |